BNIP3L expression was assessed by both RT–PCR and Northern blot analysis in breast and ovarian cancer cell lines and found to be expressed at similar levels relative to expression in their respective normal epithelial cell lines. This evidence concerns the gene BNIP3L and ovarian carcinoma.